Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Health Promotion × Thoracic × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3 Other solid neoplasm 2 Breast 2 Thoracic 1 Plasma cell 1 Other neoplasm 1 Other 1 Myeloid 1 Lymphoid 1 Gastrointestinal 1 Dermatologic 1 Classical hematology 1

Conditions

Lung Neoplasms 1

Interventions

Carboplatin 196 pembrolizumab 173 Pemetrexed 145 Cisplatin 119 Paclitaxel 83 durvalumab 77 Nivolumab 69 atezolizumab 67 Specimen Handling 66 osimertinib 57 Docetaxel 54 Magnetic Resonance Spectroscopy 50 Gemcitabine 42 Radiosurgery 36 Radiotherapy 35 Etoposide 32 cemiplimab 31 Drug Therapy 30 130-nm albumin-bound paclitaxel 30 Ipilimumab 29 Bevacizumab 29 Immunoglobulin G 21 Cetuximab 21 Biopsy 21 Taxes 20 Disulfides 20 tislelizumab 18 amivantamab 18 Platinum 18 Standard of Care 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04783168 2026-04-16

AIRTECH

M.D. Anderson Cancer Center

Phase NA Recruiting

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡